Literature DB >> 21884133

Economic analysis of nutrition interventions for chronic disease prevention: methods, research, and policy.

John B Wong1, Paul M Coates, Robert M Russell, Johanna T Dwyer, James A Schuttinga, Barbara A Bowman, Sarah A Peterson.   

Abstract

Increased interest in the potential societal benefit of incorporating health economics as a part of clinical translational science, particularly nutrition interventions, led the Office of Dietary Supplements at the National Institutes of Health to sponsor a conference to address key questions about the economic analysis of nutrition interventions to enhance communication among health economic methodologists, researchers, reimbursement policy makers, and regulators. Issues discussed included the state of the science, such as what health economic methods are currently used to judge the burden of illness, interventions, or healthcare policies, and what new research methodologies are available or needed to address knowledge and methodological gaps or barriers. Research applications included existing evidence-based health economic research activities in nutrition that are ongoing or planned at federal agencies. International and US regulatory, policy, and clinical practice perspectives included a discussion of how research results can help regulators and policy makers within government make nutrition policy decisions, and how economics affects clinical guideline development.
© 2011 International Life Sciences Institute.

Entities:  

Mesh:

Year:  2011        PMID: 21884133      PMCID: PMC3170130          DOI: 10.1111/j.1753-4887.2011.00412.x

Source DB:  PubMed          Journal:  Nutr Rev        ISSN: 0029-6643            Impact factor:   7.110


  35 in total

1.  Addressing uncertainty in medical cost-effectiveness analysis implications of expected utility maximization for methods to perform sensitivity analysis and the use of cost-effectiveness analysis to set priorities for medical research.

Authors:  D Meltzer
Journal:  J Health Econ       Date:  2001-01       Impact factor: 3.883

Review 2.  The significance of quality of life in health care.

Authors:  Robert M Kaplan
Journal:  Qual Life Res       Date:  2003       Impact factor: 4.147

3.  Does Medicare have an implicit cost-effectiveness threshold?

Authors:  James D Chambers; Peter J Neumann; Martin J Buxton
Journal:  Med Decis Making       Date:  2010-06-15       Impact factor: 2.583

4.  Use of chromium picolinate and biotin in the management of type 2 diabetes: an economic analysis.

Authors:  Joseph P Fuhr; Hope He; Neil Goldfarb; David B Nash
Journal:  Dis Manag       Date:  2005-08

5.  Reevaluating the benefits of folic acid fortification in the United States: economic analysis, regulation, and public health.

Authors:  Scott D Grosse; Norman J Waitzman; Patrick S Romano; Joseph Mulinare
Journal:  Am J Public Health       Date:  2005-09-29       Impact factor: 9.308

6.  Disease and disadvantage in the United States and in England.

Authors:  James Banks; Michael Marmot; Zoe Oldfield; James P Smith
Journal:  JAMA       Date:  2006-05-03       Impact factor: 56.272

7.  The cost-effectiveness of omega-3 supplements for prevention of secondary coronary events.

Authors:  Jordana K Schmier; Nancy J Rachman; Michael T Halpern
Journal:  Manag Care       Date:  2006-04

Review 8.  Clinical economics. A guide to the economic analysis of clinical practices.

Authors:  J M Eisenberg
Journal:  JAMA       Date:  1989-11-24       Impact factor: 56.272

9.  Effect of multivitamin and multimineral supplements on morbidity from infections in older people (MAVIS trial): pragmatic, randomised, double blind, placebo controlled trial.

Authors:  Alison Avenell; Marion K Campbell; Jonathan A Cook; Philip C Hannaford; Mary M Kilonzo; Geraldine McNeill; Anne C Milne; Craig R Ramsay; D Gwyn Seymour; Audrey I Stephen; Luke D Vale
Journal:  BMJ       Date:  2005-08-06

10.  Cost-effectiveness analysis of n-3 polyunsaturated fatty acids (PUFA) after myocardial infarction: results from Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-Prevenzione Trial.

Authors:  M G Franzosi; M Brunetti; R Marchioli; R M Marfisi; G Tognoni; F Valagussa
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

View more
  3 in total

1.  Vitamin/trace mineral supplements for the elderly.

Authors:  Donald B McCormick
Journal:  Adv Nutr       Date:  2012-11-01       Impact factor: 8.701

2.  Trends in research on energy balance supported by the National Cancer Institute.

Authors:  Rachel Ballard-Barbash; Sameer M Siddiqi; David A Berrigan; Sharon A Ross; Linda C Nebeling; Emily C Dowling
Journal:  Am J Prev Med       Date:  2013-04       Impact factor: 5.043

3.  Clinical and Molecular-Genetic Insights into the Role of Oxidative Stress in Diabetic Retinopathy: Antioxidant Strategies and Future Avenues.

Authors:  Silvia M Sanz-González; José J García-Medina; Vicente Zanón-Moreno; María I López-Gálvez; David Galarreta-Mira; Lilianne Duarte; Mar Valero-Velló; Ana I Ramírez; J Fernando Arévalo; María D Pinazo-Durán
Journal:  Antioxidants (Basel)       Date:  2020-11-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.